TDOC
TDOC
NYSE · Health Care

Teladoc Health Inc

$9.41
-0.29 (-2.99%)
Financial Highlights (FY 2026)
Revenue
2.51B
Net Income
-199,077,419
Gross Margin
69.5%
Profit Margin
-7.9%
Rev Growth
+1.7%
D/E Ratio
0.72
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 69.5% 69.5% 59.9% 59.9%
Operating Margin -10.4% -9.4% 14.5% 12.7%
Profit Margin -7.9% -7.5% 11.4% 11.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.51B 2.47B 196.92M 169.36M
Gross Profit 1.75B 1.72B 118.05M 101.52M
Operating Income -261,222,833 -231,216,118 28.47M 21.48M
Net Income -199,077,419 -176,209,359 22.43M 19.47M
Gross Margin 69.5% 69.5% 59.9% 59.9%
Operating Margin -10.4% -9.4% 14.5% 12.7%
Profit Margin -7.9% -7.5% 11.4% 11.5%
Rev Growth +1.7% +1.7% +7.3% +5.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 319.10M 319.10M 331.89M 372.61M
Total Equity 444.43M 444.43M 654.10M 617.48M
D/E Ratio 0.72 0.72 0.51 0.60
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 100.48M 93.88M 39.52M 34.03M
Free Cash Flow — — 11.14M 11.84M